Are you waiting to hear from the TGA about your new medical device or IVD application? Maybe it’s an application audit response…. read on for more information about TGA time frames… There are two categories of time frames used within the Australian medical devices regulatory framework. These are as follows: 1. Legislated time frames: these are times that are specified within the Therapeutic Goods Act 1989 (the Act) and the Therapeutic Goods (Medical Devices) Regulations 2002. 2. Target time frames: these are anticipated time frames that......
Continue Reading
The TGA announced the reclassification of hip, knee and shoulder joint implants (total and partial) in 2012. The announcement required medical device manufacturers and sponsors to update their product certification and Australian Register for Therapeutic Goods (ARTG) inclusion – transitioning from a Class IIa/IIb to a Class III. A transition period was granted however this is due to conclude on the 30th June 2014. As described in our news story dated September 2012, reclassification applies to a number of products. The GMDN codes associated with affected devices on the Australian Register for Therapeutic......
Continue Reading
Product development is an all consuming process, taking considerable time and effort. An important activity associated with product development is the building of Technical Documentation to support your medical device for regulatory submissions. Technical Documentation is used describe a medical device and specify how a manufacturer has demonstrated that the product is safe and performs as they intend it to (in normal conditions). Building Technical Documentation is a complex and detailed task. Some key factors, which feed into Technical Documentation, to consider in the early stages as part of product development are......
Continue Reading
To assist in the development and support of clients in Eastern Australia KD&A is opening a new office in Sydney. We also have a new location for our Adelaide office. We look forward to continuing to work with you as you develop your products and businesses. Please do not hesitate to contact us....
Continue Reading
In February, KD&A’s Adelaide office moved to a new address. Our phone number has changed and our new contact details are below. 36-38 Glen Osmond Road Parkside, South Australia 5063 Phone: +61 4 11 101 392 kdent@kdas.com.au...
Continue Reading
Planning is a recognised and vital step in the development of any medical device…. planning of design, manufacture, customer requirements … the list goes on. However regulatory requirements are often disregarded until submissions for certification is required. The regulatory framework surrounding medical and IVD devices is complex – insufficient planning from the beginning can result in significant delay and cost for manufacturers and distributors who haven’t factored regulatory requirements into their overall plan. Whether we like it or not, regulatory compliance is a vital piece of the pie when it comes to......
Continue Reading
KD&A provide expert medical device and IVD regulatory guidance to help launch products and access new markets. Our services include regulatory strategy, product registration for Australian (TGA), EU (CE Marking), United States (FDA) and Canadian markets, as well as ISO and GMP quality system compliance. Regulatory Strategy Development of a sound regulatory strategy is an essential starting point for medical device and IVD manufacturers. Designed to provide your organisation with an understanding of specific regulatory requirements in chosen target markets, a Regulatory Strategy Report is your road map to market. Quality Management......
Continue Reading
The TGA have introduced a new online MDIR System for sponsors and manufacturers which is accessible via their eBusiness system (also used to submit applications). The eBusiness system can only be accessed by companies who have completed a TGA Client Details Form to establish themselves with the TGA (and have the necessary eBusiness username and password). The System is designed to improve ongoing reporting and monitoring for adverse events which have been reported to the TGA using the online adverse event incident reporting form (acessible here or from an eBusiness account). The......
Continue Reading
The International Medical Device Regulators Forum (IMDRF) began work on developing documentation to facilitate the Medical Device Single Audit Program (MDSAP) in Singapore in 2012. The Pilot Program is now due to begin in 2014 and will bring a new era for medical device manufacturers. The global approach to consistent audit requirements is hoped to facilitate improved monitoring of devices and reduce burden for manufacturers. The MDSAP is designed to ensure a single audit of a medical device manufacturer will provide efficient and thorough coverage of the diverse international regulatory requirements of......
Continue Reading
2013 is quickly drawing to a close – ensure you carry out a regulatory and quality management system (QMS) tidy up within your organisation before the Christmas break is here. KD&A recommend the following tasks: Complete product registration for medical devices (including IVDDs) that your organisation wish to place on the market in 2014. Ensure all outstanding QMS activities are seen to. Review registers and forms to ensure they’re suitably complete. Consider scheduling internal auditing, standards review, post market surveillance and management review activities for 2014 – adding reminders to your diary......
Continue Reading